Filing step-change
MAPROIN · 2026-09
Quarterly observations that moved versus the prior period in 2026-09. Facts only — not a call to act.
Narrative date 2026-09-30 · Evidence medium
The market experienced a significant shift in the performance of MAPROIN on September 30, 2026.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | 27.09 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 27.09 % | 136.32 | ▼ |
Cite this
Source: Samhati filing step-change for MAPROIN (2026-09). Observation: The market experienced a significant shift in the performance of MAPROIN on September 30, 2026. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/maproin/q/2026-09
Other periods